Literature DB >> 34316004

The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats.

Cristiane Ribeiro de Carvalho1,2, Mark William Lopes3,4, Leandra C Constantino1,2, Alexandre Ademar Hoeller2,5, Hiago Murilo de Melo1,2, Ricardo Guarnieri2,6,7,8, Marcelo Neves Linhares2,6,7,9, Zuner Assis Bortolotto10, Rui Daniel Prediger1,2,11, Alexandra Latini12, Katia Lin2,5,7,13, Julio Licinio14, Rodrigo Bainy Leal1,2,3,15, Roger Walz16,17,18,19,20.   

Abstract

We demonstrate that the rate of extracellular signal-related kinase phosphorylation (P-ERK1,2/Total-ERK1,2) in the amygdala is negatively and independently associated with anxiety symptoms in 23 consecutive patients with drug-resistant mesial temporal lobe epilepsy that was surgically treated. In naive Wistar rats, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala correlates negatively with innate anxiety-related behavior on the elevated plus maze (n = 20) but positively with expression of defensive-learned behavior (i.e., freezing) on Pavlovian aversive (fear) conditioning (n = 29). The microinfusion of ERK1/2 inhibitor (FR180204, n = 8-13/group) or MEK inhibitor (U0126, n = 8-9/group) into the basolateral amygdala did not affect anxiety-related behavior but impaired the evocation (anticipation) of conditioned-defensive behavior (n = 9-11/group). In conclusion, the P-ERK1,2/Total-ERK1,2 ratio in the amygdala predicts anxiety in humans and the innate anxiety- and conditioned freezing behaviors in rats. However, the ERK1/2 in the basolateral AMY is only required for the expression of defensive-learned behavior. These results support a dissociate ERK-dependent mechanism in the amygdala between innate anxiety-like responses and the anticipation of learned-defensive behavior. These findings have implications for understanding highly prevalent psychiatric disorders related to the defensive circuit manifested by anxiety and fear. HIGHLIGHTS: The P-ERK1,2/Total-ERK1,2 ratio in the amygdala (AMY) correlates negatively with anxiety symptoms in patients with mesial temporal lobe epilepsy. The P-ERK1,2/Total-ERK1,2 in the amygdala correlates negatively with the anxiety-like behavior and positively with freezing-learned behavior in naive rats. ERK1,2 in the basolateral amygdala is required for learned-defensive but not for the anxiety-like behavior expression in rats.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34316004     DOI: 10.1038/s41380-021-01203-0

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  46 in total

Review 1.  Differences between trait fear and trait anxiety: implications for psychopathology.

Authors:  Patrick Sylvers; Scott O Lilienfeld; Jamie L LaPrairie
Journal:  Clin Psychol Rev       Date:  2010-08-14

2.  Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative.

Authors:  Ronald C Kessler; Matthias Angermeyer; James C Anthony; Ron DE Graaf; Koen Demyttenaere; Isabelle Gasquet; Giovanni DE Girolamo; Semyon Gluzman; Oye Gureje; Josep Maria Haro; Norito Kawakami; Aimee Karam; Daphna Levinson; Maria Elena Medina Mora; Mark A Oakley Browne; José Posada-Villa; Dan J Stein; Cheuk Him Adley Tsang; Sergio Aguilar-Gaxiola; Jordi Alonso; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Patricia Berglund; Michael J Gruber; Maria Petukhova; Somnath Chatterji; T Bedirhan Ustün
Journal:  World Psychiatry       Date:  2007-10       Impact factor: 49.548

Review 3.  Using Neuroscience to Help Understand Fear and Anxiety: A Two-System Framework.

Authors:  Joseph E LeDoux; Daniel S Pine
Journal:  Am J Psychiatry       Date:  2016-09-09       Impact factor: 18.112

4.  Pavlovian fear conditioning regulates Thr286 autophosphorylation of Ca2+/calmodulin-dependent protein kinase II at lateral amygdala synapses.

Authors:  Sarina M Rodrigues; Claudia R Farb; Elizabeth P Bauer; Joseph E LeDoux; Glenn E Schafe
Journal:  J Neurosci       Date:  2004-03-31       Impact factor: 6.167

5.  Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II.

Authors:  C Chen; D G Rainnie; R W Greene; S Tonegawa
Journal:  Science       Date:  1994-10-14       Impact factor: 47.728

6.  The clinical implications of mouse models of enhanced anxiety.

Authors:  Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Future Neurol       Date:  2011-07-01

Review 7.  Animal models of anxiety disorders in rats and mice: some conceptual issues.

Authors:  Thierry Steimer
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 8.  Neurobehavioral perspectives on the distinction between fear and anxiety.

Authors:  Jennifer N Perusini; Michael S Fanselow
Journal:  Learn Mem       Date:  2015-08-18       Impact factor: 2.460

Review 9.  The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB.

Authors:  Eric R Kandel
Journal:  Mol Brain       Date:  2012-05-14       Impact factor: 4.041

10.  ERK1/2: A Key Cellular Component for the Formation, Retrieval, Reconsolidation and Persistence of Memory.

Authors:  Jorge H Medina; Haydee Viola
Journal:  Front Mol Neurosci       Date:  2018-10-05       Impact factor: 5.639

View more
  2 in total

1.  Functional Connectivity Features of Resting-State Functional Magnetic Resonance Imaging May Distinguish Migraine From Tension-Type Headache.

Authors:  Yajuan Wang; Yingshuang Wang; Lihong Bu; Shaoyang Wang; Xinhui Xie; Fuchun Lin; Zheman Xiao
Journal:  Front Neurosci       Date:  2022-04-26       Impact factor: 5.152

2.  Early Life Stress Induces Different Behaviors in Adolescence and Adulthood May Related With Abnormal Medial Prefrontal Cortex Excitation/Inhibition Balance.

Authors:  Yiwen Chen; Yuanjia Zheng; Jinglan Yan; Chuanan Zhu; Xuan Zeng; Shaoyi Zheng; Wenwen Li; Lin Yao; Yucen Xia; Wei-Wei Su; Yongjun Chen
Journal:  Front Neurosci       Date:  2022-01-04       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.